VLST Corp. Cuts Scientific Group as Focus Shifts to Clinical Trials
9/27/2012 8:38:36 AM
More...
|
VLST Corp. Scoops Up Antibody for Cancer From Pfizer Inc. (PFE)
8/31/2012 7:23:49 AM
More...
|
Theraclone Sciences, Inc. and VLST Corp. Creators Form V-Gene
1/27/2012 7:59:39 AM
More...
|
VLST Corp. Appoints Brian Blackman as Vice President, Finance & Administration
6/13/2011 9:49:07 AM
More...
|
AnaptysBio, Inc. Announces Collaboration with VLST Corp. to Generate Novel Antibody Therapeutics
4/5/2010 9:03:38 AM
More...
|
VLST Corp. Cuts Jobs To Preserve Cash, Still Feeding Novo Nordisk A/S (NVO) Pipeline
12/22/2009 7:58:50 AM
More...
|
VLST Corp. and Novo Nordisk, Inc. (NVO) Announce Collaboration Agreement to Develop Therapeutics for Autoimmune and Inflammatory Disorders
12/17/2008 6:26:35 AM
More...
|
VLST Corp. Appoints Internationally Recognized Researcher Paul J. Carter, Ph.D. as Chief Scientific Officer
7/2/2008 9:29:05 AM
More...
|
VLST Corp. Announces Board and Executive Management Appointments
2/13/2008 11:55:33 AM
More...
|
VLST Corp. Names Consuelo M. Blosch, M.D., Vice President of Clinical and Regulatory and Dan Allison, Ph.D., Sr. Director of Therapeutic Design
9/17/2007 8:16:58 AM
More...
|
|